Lihong Wu

2.6k total citations
118 papers, 1.5k citations indexed

About

Lihong Wu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lihong Wu has authored 118 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 28 papers in Cancer Research and 25 papers in Oncology. Recurrent topics in Lihong Wu's work include Cancer-related molecular mechanisms research (15 papers), MicroRNA in disease regulation (14 papers) and RNA modifications and cancer (13 papers). Lihong Wu is often cited by papers focused on Cancer-related molecular mechanisms research (15 papers), MicroRNA in disease regulation (14 papers) and RNA modifications and cancer (13 papers). Lihong Wu collaborates with scholars based in China, United States and Netherlands. Lihong Wu's co-authors include Janak L. Pathak, Jinliang Kong, Changchun Hou, Yuejin Liang, Hong Huang, Yiqiang Chen, Xiaowen Zheng, Nan Bi, Dan Hou and Jing Luo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Lihong Wu

112 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lihong Wu China 19 582 362 189 188 174 118 1.5k
Rui Bai China 24 709 1.2× 315 0.9× 116 0.6× 170 0.9× 164 0.9× 128 2.0k
Indranil Chattopadhyay India 21 725 1.2× 166 0.5× 191 1.0× 221 1.2× 108 0.6× 45 1.5k
Xin Xie China 23 782 1.3× 374 1.0× 140 0.7× 130 0.7× 185 1.1× 85 1.9k
Yanni Yu United States 25 738 1.3× 178 0.5× 229 1.2× 307 1.6× 226 1.3× 83 2.0k
Cláudio J. Maia Portugal 22 634 1.1× 238 0.7× 292 1.5× 229 1.2× 157 0.9× 69 1.7k
Qiang Xiao China 21 536 0.9× 242 0.7× 252 1.3× 290 1.5× 339 1.9× 40 2.0k
Liang Guo China 23 543 0.9× 271 0.7× 160 0.8× 197 1.0× 132 0.8× 116 1.8k
Yun Feng China 26 709 1.2× 216 0.6× 252 1.3× 228 1.2× 255 1.5× 106 2.0k
Hui Liang China 24 726 1.2× 301 0.8× 429 2.3× 294 1.6× 145 0.8× 152 1.9k
Yu Zhou China 26 767 1.3× 308 0.9× 151 0.8× 260 1.4× 429 2.5× 105 1.9k

Countries citing papers authored by Lihong Wu

Since Specialization
Citations

This map shows the geographic impact of Lihong Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lihong Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lihong Wu more than expected).

Fields of papers citing papers by Lihong Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lihong Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lihong Wu. The network helps show where Lihong Wu may publish in the future.

Co-authorship network of co-authors of Lihong Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Lihong Wu. A scholar is included among the top collaborators of Lihong Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lihong Wu. Lihong Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Ce, Song Zhang, Xu Zheng, et al.. (2025). Double-layer coated Csf/SiC composite fabricated by LPBF/LSI with improved mechanical properties through fiber damage prevention and crack propagation inhibition. Journal of the European Ceramic Society. 45(7). 117248–117248. 1 indexed citations
2.
Guo, Donglin, Huixia Gao, Lihong Wu, et al.. (2025). Application value of nucleic acid MALDI-TOF MS in mycobacterial species identification and drug resistance detection in Mycobacterium tuberculosis. Microbiology Spectrum. 13(5). e0154524–e0154524. 2 indexed citations
3.
Hou, Dan, et al.. (2025). Dynamic Visualization of Computer-Aided Peptide Design for Cancer Therapeutics. Drug Design Development and Therapy. Volume 19. 1043–1065. 5 indexed citations
4.
Wu, Weixiang, et al.. (2024). Interaction effects of MTHFR C677T and A1298C polymorphisms with maternal glycated haemoglobin levels on adverse birth outcomes. Diabetes/Metabolism Research and Reviews. 40(3). e3794–e3794. 2 indexed citations
5.
Zheng, Zhichao, et al.. (2024). GelMA - PVAMA hydrogel loaded with MYDGF accelerates wound healing by promoting angiogenesis. International Journal of Polymeric Materials. 73(18). 1569–1578. 1 indexed citations
6.
Zheng, Zhichao, Janak L. Pathak, Zi Fu, et al.. (2024). GHK-Cu/Pionin-loaded in situ electrospun PVB/PVP smart dressing promotes wound healing via anti-oxidant, anti-inflammatory, antimicrobial, and tissue regenerative effects. Chemical Engineering Journal. 492. 152154–152154. 14 indexed citations
8.
Wang, Dongping, Lihong Wu, Rui Li, et al.. (2023). A Novel Aldisine Derivative Exhibits Potential Antitumor Effects by Targeting JAK/STAT3 Signaling. Marine Drugs. 21(4). 218–218. 7 indexed citations
9.
Zhang, Siying, Lihong Wu, Zhiyi Wei, et al.. (2023). Trend and heterogeneity in forced vital capacity among Chinese students during 1985–2019: results from Chinese National Survey on Students’ Constitution and Health. Respiratory Research. 24(1). 268–268. 2 indexed citations
10.
He, Na, Rui Li, Siqi Zhang, et al.. (2023). A Novel Ageladine A Derivative Acts as a STAT3 Inhibitor and Exhibits Potential Antitumor Effects. International Journal of Molecular Sciences. 24(10). 8859–8859. 1 indexed citations
11.
Wang, Xiang-Xu, Lihong Wu, Qingqing Liu, et al.. (2023). Cuproptosis-Mediated Patterns Characterized by Distinct Tumor Microenvironment and Predicted the Immunotherapy Response for Gastric Cancer. ACS Omega. 8(12). 10851–10862. 10 indexed citations
12.
Zheng, Zhichao, Lihong Wu, Zhicong Li, et al.. (2023). Mir155 regulates osteogenesis and bone mass phenotype via targeting S1pr1 gene. eLife. 12. 5 indexed citations
13.
Zhang, Qing, Dan Hou, Xueying Wen, et al.. (2022). Gold nanomaterials for oral cancer diagnosis and therapy: Advances, challenges, and prospects. Materials Today Bio. 15. 100333–100333. 39 indexed citations
14.
Liu, Lizhu, Lihong Wu, Dan Shan, & Bo Han. (2022). Characterization and clinical relevance of PDGFRA pathway copy number variation gains across human cancers. Molecular Genetics and Genomics. 297(2). 561–571. 4 indexed citations
15.
Wang, Haiyan, Yongyong Yan, Nan Wei, et al.. (2022). Notoginsenoside R1 Promotes Migration, Adhesin, Spreading, and Osteogenic Differentiation of Human Adipose Tissue-Derived Mesenchymal Stromal Cells. Molecules. 27(11). 3403–3403. 8 indexed citations
16.
Zhang, Siyu, Weiyan Hu, Mengran Li, et al.. (2021). Multiscale research on spatial supply-demand mismatches and synergic strategies of multifunctional cultivated land. Journal of Environmental Management. 299. 113605–113605. 58 indexed citations
17.
Wang, Xiang-Xu, et al.. (2021). Construction of an HCC recurrence model based on the investigation of immune-related lncRNAs and related mechanisms. Molecular Therapy — Nucleic Acids. 26. 1387–1400. 10 indexed citations
18.
He, Youling, Weiwei Feng, Yan Wang, et al.. (2021). A near infrared photothermal therapy hydrogel with high conversion efficiency for eliminating of breast cancer cells. Materials Today Communications. 28. 102519–102519. 6 indexed citations
19.
Zhang, Linlin, et al.. (2021). Disorder of three‐dimensional chromosome structure plays a role in carcinogenesis. SHILAP Revista de lepidopterología. 1(1).
20.
Wu, Lihong, et al.. (2013). Research on Laser Welding Joint Residual Stress of SUS301L Austenitic Stainless Steel for Subway. Rejiagong gongyi.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026